Novel human transitional B cell populations revealed by B cell depletion therapy

Journal of Immunology

Volumn 182, Issue 10, 2009, Pages 5982-5993

  Palanichamy, Arumugam ^a   Barnard, Jennifer ^a   Zheng, Bo ^a   Owen, Teresa ^a   Quach, Tam ^a   Wei, Chungwen ^a   Looney, R John ^a   Sanz, Iñaki ^a   Anolik, Jennifer H ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAKPOINT CLUSTER REGION PROTEIN; CD24 ANTIGEN; CD38 ANTIGEN; RITUXIMAB;

ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; BONE MARROW; CALCIUM TRANSPORT; CELL COMPARTMENTALIZATION; CELL SURVIVAL; CELL THERAPY; CONTROLLED STUDY; HUMAN; HUMAN CELL; LUPUS ERYTHEMATOSUS; LYMPHOCYTE CULTURE; LYMPHOCYTE DEPLETION; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; LYMPHOCYTE TYPING; PRIORITY JOURNAL; PROTEIN CROSS LINKING; RHEUMATOID ARTHRITIS; SPLEEN; TRANSITIONAL B CELL POPULATION; UMBILICAL CORD BLOOD; UPREGULATION;

ANIMALS; B-LYMPHOCYTE SUBSETS; B-LYMPHOCYTES; CELL DIFFERENTIATION; FLOW CYTOMETRY; HUMANS; LYMPHOCYTE DEPLETION; MICE; PHENOTYPE; PRECURSOR CELLS, B-LYMPHOID;

EID: 72449140060     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0801859     Document Type: Article

References (33)

1. Chung, J. B., M. Silverman, and J. G. Monroe. 2003. Transitional B cells: step by step towards immune competence. Trends Immunol. 24: 342-348.
2. Carsetti, R., G. Kohler, and M. C. Lamers. 1995. Transitional B cells are the target of negative selection in the B cell compartment. J. Exp. Med. 181: 2129-2140.
3. Loder, F., B. Mutschler, R. J. Ray, C. J. Paige, P. Sideras, R. Torres, M. C. Lamers, and R. Carsetti. 1999. B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals. J. Exp. Med. 190: 75-89. (Pubitemid 29330125)
4. Su, T. T., and D. J. Rawlings. 2002. Transitional B lymphocyte subsets operate as distinct checkpoints in murine splenic B cell development. J. Immunol. 168: 2101-2110.
5. Wardemann, H., S. Yurasov, A. Schaefer, J. W. Young, E. Meffre, and M. C. Nussenzweig. 2003. Predominant autoantibody production by early human B cell precursors. Science 301: 1374-1377. (Pubitemid 37075812)
6. Yurasov, S., H. Wardemann, J. Hammersen, M. Tsuiji, E. Meffre, V. Pascual, and M. C. Nussenzweig. 2005. Defective B cell tolerance checkpoints in systemic lupus erythematosus. J. Exp. Med. 201: 703-711. (Pubitemid 40395116)
7. Sims, G. P., R. Ettinger, Y. Shirota, C. H. Yarboro, G. G. Illei, and P. E. Lipsky. 2005. Identification and characterization of circulating human transitional B cells. Blood 105: 4390-4398. (Pubitemid 40720786)
8. Cuss, A. K., D. T. Avery, J. L. Cannons, L. J. Yu, K. E. Nichols, P. J. Shaw, and S. G. Tangye. 2006. Expansion of functionally immature transitional B cells is associated with human-immunodeficient states characterized by impaired humoral immunity. J. Immunol. 176: 1506-1516.
9. Allman, D., R. C. Lindsley, W. DeMuth, K. Rudd, S. A. Shinton, and R. R. Hardy. 2001. Resolution of three nonproliferative immature splenic B cell subsets reveals multiple selection points during peripheral B cell maturation. J. Immunol. 167: 6834-6840. (Pubitemid 33144175)
10. Srivastava, B., W. J. Quinn III, K. Hazard, J. Erikson, and D. Allman. 2005. Characterization of marginal zone B cell precursors. J. Exp. Med. 202: 1225-1234. (Pubitemid 41586953)
11. Carsetti, R., M. M. Rosado, and H. Wardmann. 2004. Peripheral development of B cells in mouse and man. Immunol. Rev. 197: 179-191. (Pubitemid 38142176)
12. Merrell, K. T., R. J. Benschop, S. B. Gauld, K. Aviszus, D. Decote-Ricardo, L. J. Wysocki, and J. C. Cambier. 2006. Identification of anergic B cells within a wild-type repertoire. Immunity 25: 953-962.
13. Anolik, J., J. Barnard, T. Owen, B. Zheng, S. Kemshett, J. Looney, and I. Sanz. 2007. Delayed memory B cell recovery in peripheral blood and lymphoid tissue in systemic lupus erythematosus after B cell depletion therapy. Arthritis Rheum. 56: 3044-3056. (Pubitemid 47502752)
14. Roll, P., A. Palanichamy, C. Kneitz, T. Dorner, and H. P. Tony. 2006. Regeneration of B cell subsets after transient B cell depletion using anti-CD20 antibodies in rheumatoid arthritis. Arthritis Rheum. 54: 2377-2386. (Pubitemid 44204997)
15. Anolik, J. H., J. W. Friedberg, B. Zheng, J. Barnard, T. Owen, E. Cushing, J. Kelly, E. C. B. Milner, R. I. Fisher, and I. Sanz. 2007. B cell reconstitution after rituximab treatment of lymphoma recapitulates B cell ontogeny. Clin. Immunol. 122: 139-145. (Pubitemid 46073890)
16. Looney, R. J., J. H. Anolik, D. Campbell, R. E. Felgar, F. Young, L. J. Arend, J. A. Sloand, J. Rosenblatt, and I. Sanz. 2004. B cell depletion as a novel treatment for systemic lupus erythematosus: a phase I/II dose-escalation trial of rituximab. Arthritis Rheum. 50: 2580-2589.
17. Pascual, V., Y. J. Liu, A. Magalski, O. de Bouteiller, J. Banchereau, and J. D. Capra. 1994. Analysis of somatic mutation in five B cell subsets of human tonsil. J. Exp. Med. 180: 329-339. (Pubitemid 24181081)
18. Bornhorst, J., M. Bjorgan, J. Thoen, J. Natvig, and K. Thompson. 2001. Bm1-Bm5 classification of peripheral blood B cells reveals circulating germinal center founder cells in healthy individuals and disturbance in the B cell subpopulations in patients with primary Sjögren's syndrome. J. Immunol. 167: 3610-3618.
19. Wirth, S., and A. Lanzavecchia. 2005. ABCB1 transporter discriminates human resting naive B cells from cycling transitional and memory B cells. Eur. J. Immunol. 35: 3433-3441.
20. Loken, M. R., V. O. Shah, K. L. Dattilio, and C. I. Civin. 1987. Flow cytometric analysis of human BM: II. Normal B lymphocyte development. Blood 70: 1316-1324. (Pubitemid 18026132)
21. Wei, C., J. Anolik, A. Cappione, B. Zheng, A. Pugh-Bernard, J. Brooks, E.-H. Lee, E. C. B. Milner, and I. Sanz. 2007. A new population of cells lacking expression of CD27 represents a notable component of the B cell memory compartment in systemic lupus erythematosus. J. Immunol. 178: 6624-6633. (Pubitemid 46717447)
22. Evans, J. G., K. A. Chavez-Rueda, A. Eddaoudi, A. Meyer-Bahlburg, D. J. Rawlings, M. R. Ehrenstein, and C. Mauri. 2007. Novel suppressive function of transitional 2 B cells in experimental arthritis. J. Immunol. 178: 7868-7878.
23. Dono, M., S. Zupo, M. Colombo, R. Massara, G. Gaidano, G. Taborelli, P. Ceppa, V. L. Burgio, N. Chiorazzi, and M. Ferrarini. 2003. The human marginal zone B cell. Ann. NY Acad. Sci. 987: 117-124.
24. Meyer-Bahlburg, A., S. F. Andrews, K. O. Yu, S. A. Porcelli, and D. J. Rawlings. 2008. Characterization of a late transitional B cell population highly sensitive to BAFF-mediated homeostatic proliferation. J. Exp. Med. 205: 155-168. (Pubitemid 351185723)
25. Wells, A. D., H. Gudmundsdottir, and L. A. Turka. 1997. Following the fate of individual T cells throughout activation and clonal expansion: signals from T cell receptor and CD28 differentially regulate the induction and duration of a proliferative response. J. Clin. Invest. 100: 3173-3183.
26. Malaspina, A., S. Moir, J. Ho, W. Wang, M. L. Howell, M. A. O'Shea, G. A. Roby, C. A. Rehm, J. M. Mican, T. W. Chun, and A. S. Fauci. 2006. Appearance of immature/transitional B cells in HIV-infected individuals with advanced disease: correlation with increased IL-7. Proc. Natl. Acad. Sci. USA 103: 2262-2267. (Pubitemid 43271658)
27. Capolunghi, F., S. Cascioli, E. Giorda, M. M. Rosado, A. Plebani, C. Auriti, G. Seganti, R. Zuntini, S. Ferrari, M. Cagliuso, et al. 2008. CpG drives human transitional B cells to terminal differentiation and production of natural antibodies. J. Immunol. 180: 800-808.
28. Cabatingan, M. S., M. R. Schmidt, R. Sen, and R. T. Woodland. 2002. Naive B lymphocytes undergo homeostatic proliferation in response to B cell deficit. J. Immunol. 169: 6795-6805.
29. Sanz, I., C. Wei, F. E.-H. Lee, and J. Anolik. 2008. Phenotypic and functional heterogeneity of human memory B cells. Semin. Immunol. 20: 67-82.
30. Lindsley, R. C., M. Thomas, B. Srivastava, and D. Allman. 2007. Generation of peripheral B cells occurs via two spatially and temporally distinct pathways. Blood 109: 2521-2528.
31. Carsetti, R., G. Kohler, and M. Lamers. 1995. Transitional B cells are the target of negative selection in the B cell compartment. J. Exp. Med. 181: 2129.
32. Chung, J. B., R. Sater, M. L. Fields, J. Erikson, and J. G. Monroe. 2002. CD23 defines two distinct subsets of immature B cells which differ in their responses to T cell help signals. Int. Immunol. 14: 157-166.
33. Lavie, F., C. Miceli-Richard, M. Ittah, J. Sellam, J. E. Gottenberg, and X. Mariette. 2007. Increase of B cell-activating factor of the TNF family (BAFF) after rituximab treatment: insights into a new regulating system of BAFF production. Ann. Rheum. Dis. 66: 700-703. (Pubitemid 46707145)